These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18654840)

  • 1. Mus tales: a hands-on view.
    Young LJ
    J Mammary Gland Biol Neoplasia; 2008 Sep; 13(3):343-9. PubMed ID: 18654840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction in transgenic mouse models of human breast cancer--implications for human breast cancer.
    Marcotte R; Muller WJ
    J Mammary Gland Biol Neoplasia; 2008 Sep; 13(3):323-35. PubMed ID: 18651209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genomic analysis of mouse models of breast cancer reveals molecular features of mouse models and relationships to human breast cancer.
    Hollern DP; Andrechek ER
    Breast Cancer Res; 2014 Jun; 16(3):R59. PubMed ID: 25069779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse Models of Breast Cancer Share Amplification and Deletion Events with Human Breast Cancer.
    Rennhack J; To B; Wermuth H; Andrechek ER
    J Mammary Gland Biol Neoplasia; 2017 Mar; 22(1):71-84. PubMed ID: 28124185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers.
    Fougner C; Bergholtz H; Kuiper R; Norum JH; Sørlie T
    Breast Cancer Res; 2019 Jul; 21(1):85. PubMed ID: 31366361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of IL-12 gene therapy on spontaneous transgenic and transplanted breast tumors.
    Faggioli F; Soldati S; Scanziani E; Catò EM; Adorni F; Vezzoni P; Noonan DM; Sacco MG
    Breast Cancer Res Treat; 2008 Jul; 110(2):223-6. PubMed ID: 17687642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations.
    Zhang X; Podsypanina K; Huang S; Mohsin SK; Chamness GC; Hatsell S; Cowin P; Schiff R; Li Y
    Oncogene; 2005 Jun; 24(26):4220-31. PubMed ID: 15824740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.
    Huang S; Li Y; Chen Y; Podsypanina K; Chamorro M; Olshen AB; Desai KV; Tann A; Petersen D; Green JE; Varmus HE
    Genome Biol; 2005; 6(10):R84. PubMed ID: 16207355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer.
    Blanco-Aparicio C; Pérez-Gallego L; Pequeño B; Leal JF; Renner O; Carnero A
    Carcinogenesis; 2007 Mar; 28(3):584-94. PubMed ID: 17050554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation.
    Oh KB; Stanton MJ; West WW; Todd GL; Wagner KU
    Oncogene; 2007 Aug; 26(40):5950-9. PubMed ID: 17369844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential mouse tumor model for pre-clinical testing of mage-specific breast cancer vaccines.
    Sypniewska RK; Hoflack L; Bearss DJ; Gravekamp C
    Breast Cancer Res Treat; 2002 Jun; 74(3):221-33. PubMed ID: 12211215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models.
    Sutherland RL; Musgrove EA
    Breast Cancer Res; 2002; 4(1):14-7. PubMed ID: 11879554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of gene expression profiling for validating models of human breast cancer.
    Green JE; Desai KV; Ye Y; Kavanaugh C; Calvo A; Huh JI
    Toxicol Pathol; 2004; 32 Suppl 1():84-9. PubMed ID: 15209407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
    Zuo Y; Ulu A; Chang JT; Frost JA
    Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of MMTV integration locus cellular genes in breast cancer.
    Tekmal RR; Keshava N
    Front Biosci; 1997 Nov; 2():d519-26. PubMed ID: 9334290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice.
    Ko J; Shin SM; Oh YM; Lee YS; Ryoo ZY; Lee YH; Na DS; Kim JW
    Oncogene; 2004 Mar; 23(10):1950-3. PubMed ID: 14691448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relevance of mouse models to understanding the development and progression of human breast cancer.
    Allred DC; Medina D
    J Mammary Gland Biol Neoplasia; 2008 Sep; 13(3):279-88. PubMed ID: 18704660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RCAS-TVA in the mammary gland: an in vivo oncogene screen and a high fidelity model for breast transformation?
    Du Z; Li Y
    Cell Cycle; 2007 Apr; 6(7):823-6. PubMed ID: 17377492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers.
    Shai A; Pitot HC; Lambert PF
    Cancer Res; 2008 Apr; 68(8):2622-31. PubMed ID: 18413729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.
    Deeb KK; Michalowska AM; Yoon CY; Krummey SM; Hoenerhoff MJ; Kavanaugh C; Li MC; Demayo FJ; Linnoila I; Deng CX; Lee EY; Medina D; Shih JH; Green JE
    Cancer Res; 2007 Sep; 67(17):8065-80. PubMed ID: 17804718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.